力生制药：2025年第四次临时股东会决议公告

Core Viewpoint - The company, Lisheng Pharmaceutical, announced the approval of the proposal to appoint the auditing institution for the fiscal year 2025 during its fourth extraordinary shareholders' meeting [2] Group 1 - The fourth extraordinary shareholders' meeting was held on December 22 [2] - The proposal regarding the appointment of the auditing institution for the year 2025 was approved [2]